BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33310591)

  • 1. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Jun; 52():151738. PubMed ID: 33865185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of the log odds of positive lymph nodes in Western patients with resected gastric cancer: A comparison with the 8th edition of the TNM staging system.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Am J Clin Pathol; 2024 Feb; 161(2):186-196. PubMed ID: 37901915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis.
    Ergenç M; Uprak TK; Akın Mİ; Hekimoğlu EE; Çelikel ÇA; Yeğen C
    BMC Surg; 2023 Aug; 23(1):220. PubMed ID: 37550669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymph node ratio as a prognostic factor for gastric cancer.
    Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K
    Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.
    Kutlu OC; Watchell M; Dissanaike S
    Surg Oncol; 2015 Jun; 24(2):84-8. PubMed ID: 25912951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of prognostic model based on extragastric lymph nodes metastasis and lymph node ratio in node-positive gastric cancer: a retrospective cohort study based on a multicenter database.
    Zeng Y; Cai F; Wang P; Wang X; Liu Y; Zhang L; Zhang R; Chen L; Liang H; Ye Z; Deng J
    Int J Surg; 2023 Apr; 109(4):794-804. PubMed ID: 36999785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for a clinicopathological prognostic score for resected gastric cancer patients.
    DIaz Del Arco C; Estrada Muñoz L; Molina Roldán E; Ortega Medina L; García Gómez de Las Heras S; Chávez Á; Fernández Aceñero M
    Saudi J Gastroenterol; 2021; 27(1):44-53. PubMed ID: 33047677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.
    Jian-Hui C; Shi-Rong C; Hui W; Si-le C; Jian-Bo X; Er-Tao Z; Chuang-Qi C; Yu-Long H
    Tumour Biol; 2016 Aug; 37(8):11105-13. PubMed ID: 26912060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
    Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
    Hou Y; Wang X; Chen J
    World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of lymph node ratio (LNR) in patients who underwent radical gastrectomy].
    Guevara Jabiles A; Ruiz Figueroa E; Berrospi Espinoza F; Chávez Passiuri I; Young Tabusso F; Luque Vásquez C; Poquioma Rojas E; Mantilla R; Payet Meza E
    Rev Gastroenterol Peru; 2018; 38(3):253-260. PubMed ID: 30540729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
    Singh D; Mandal A
    Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
    Gu P; Deng J; Sun Z; Wang Z; Wang W; Liang H; Xu H; Zhou Z
    Surg Today; 2021 Jan; 51(1):101-110. PubMed ID: 32754844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.